
Exploring Targeted Treatments and Their AEs in EGFR-Mutated NSCLC
Alexander I. Spira, MD, PhD (Moderator) Codirector Virginia Cancer Specialists Research Institute Director, Thoracic and Phase I Program Clinical Assistant Professor, Johns Hopkins Medicine Fairfax, VA DISCUSSION QUESTIONS Have you used amivantamab ( …